NYU Dataset
Immune Responses Observed Before and After BNT162b2 mRNA Vaccine Administration in Individuals with and without History of SARS-CoV-2 Infection
UID: 10529
- Description
- To study and compare longitudinal immune responses to two-dose BNT162b2 mRNA vaccinations, investigators recruited 15 adults with a history of laboratory-confirmed COVID-19 and 21 adults who did not have COVID-19. Participants' ages ranged from 21 to 65 years old. Peripheral immune responses were assessed via blood samples drawn before and after each vaccine dose. A total of five samples were collected from each participant: baseline, post first dose (6 to 13 days after the initial vaccination), pre second dose (immediately before the second vaccination and about 21 days since initial vaccination), post second dose (7 to 12 days after the second vaccination), and one month post second dose (about 4 weeks after the second vaccination). The investigators observed strong cytotoxic CD8+ T cell responses in both cohorts following receipt of the second vaccine dose. Progressive increases in humoral and antigen-specific antibody-secreting cell (ASC) responses were observed among SARS-CoV-2-naive individuals following each vaccine dose, but not among individuals with prior infection with SARS-CoV-2.
- Timeframe
- 2021
- Geographic Coverage
-
New York (State) - New York City
Homo sapiens
Subject Domain
Population Age
Keywords
Adult (19 years - 64 years)
Senior (65 years - 79 years)
Access
- Restrictions
-
Free to All
- Instructions
- The de-identified data underlying supplemental figures can be downloaded through PubMed Central (PMC) under Supplementary Materials.
Observational
- Grant Support
-
LF-OC-20-000351/LEO Foundation
Do you have or know of a dataset that should be added to the catalog? Let us know!